Related Experiment Video

Updated: Aug 8, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.2K

The SWIB/MDM2 motif of UBE4B activates the p53 pathway

H Helena Wu1, Sarah Leng2, Yasser Abuetabh1

  • 1370 Heritage Medical Research Center, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2S2, Canada.

Molecular Therapy. Nucleic Acids
|March 3, 2023
PubMed

Insights

Targeting the UBE4B protein interaction with the tumor suppressor p53 offers a new strategy for cancer therapy. A novel UBE4B peptide blocks this interaction, activating p53

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The tumor suppressor p53 is crucial in preventing cancer, with its regulation vital for normal cell growth.
  • UBE4B, a ubiquitin ligase, negatively regulates p53 through Hdm2-mediated degradation, making the p53-UBE4B interaction a potential therapeutic target.

Purpose of the Study:

  • To investigate the interaction between UBE4B and p53.
  • To identify the specific UBE4B domain responsible for p53 binding and degradation.
  • To evaluate a novel UBE4B peptide for its potential to activate p53 functions.

Main Methods:

  • Confirmation of UBE4B's role in p53 degradation.
  • Analysis of UBE4B mutants lacking C-terminal domains.
  • Identification of the SWIB/Hdm2 motif in UBE4B crucial for p53 binding.
  • Assessment of a novel UBE4B peptide's effect on p53 activity.

Main Results:

  • The UBE4B U box does not bind p53 but is essential for its degradation.
  • C-terminal UBE4B mutants are unable to degrade p53.
  • A specific SWIB/Hdm2 motif in UBE4B is identified as critical for p53 binding.
  • A novel UBE4B peptide successfully blocks p53-UBE4B interaction, activating p53 functions like transactivation and growth inhibition.

Conclusions:

  • Targeting the p53-UBE4B interaction is a promising strategy for cancer therapy.
  • A novel UBE4B peptide can activate p53-dependent anti-cancer functions by disrupting the p53-UBE4B complex.
  • This approach offers a new avenue for p53 activation therapy in cancer treatment.
Keywords:
G1 arrestMT: Oligonucleotides: Therapies and ApplicationsUBE4Bapoptosisp53peptide

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.6K
Detection of Protein Ubiquitination09:00

Detection of Protein Ubiquitination

Published on: August 19, 2009

43.0K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K